August 2013 Newsletter

August 19, 2013:

IStent Drives Q2-2013 Procedure Share for Newer Alternative Glaucoma Surgeries to New High

Use of newer surgical alternatives has been increasing for the past year and has contributed significantly to the climb in incisional surgical volume in the second quarter of 2013.

August 19, 2013:

IVT Injection Growth Slips Again in Second Quarter to a 1.3 Percent Rate

Market expansion has slowed significantly since Q3-2012, based upon response to quarterly surveys of retinal specialists.

August 19, 2013:

Adoption Rate of ReLACS Grows in the US

The adoption rate of refractive laser-assisted cataract surgery continues to grow in the US, even as surgeons are still debating the merits of this technology.

August 19, 2013:

Ophthalmic Diagnostic Equipment Market of $2.4 Billion Expected to Grow at Rate of 4 Percent

Market Scope estimates that this market will grow to almost $3.0 billion by 2018.

August 19, 2013:

SLT Manufacturers Enter US Market After Expiration Of Key Patent

Australia-based Ellex and France-based Quantel Medical are each targeting the US after expiration of a key patent.

August 19, 2013:

Bipartisan Measure to Repeal SGR Formula Heads to House Floor

The bill was voted out of the House Energy and Commerce Committee unanimously on July 31.

August 19, 2013:

Valeant Begins Retooling Bausch + Lomb

Canada-based Valeant announced big changes for Bausch + Lomb prior to completing its $8.7 billion acquisition of the company.

August 19, 2013:

August 2013 News Briefs

Social media